LUXendins reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics (2019)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/557132
Publication URI: https://www.biorxiv.org/content/10.1101/557132v1
Type: Preprint